https://orcid.org/0000-0001-6875-7374
References
- Tullman MJ. Overview of the epidemiology, diagnosis, and disease progression associated with multiple sclerosis. Am J Manag Care. 2013;19(2 Suppl):S15–S20.
- National Multiple Sclerosis Society. Fatigue: what you should know. A guide for people with MS. Consumer Guide to Clinical Practice Guidelines. 2019; Availbale from: https://www.nationalmssociety.org/NationalMSSociety/media/MSNationalFiles/Brochures/Brochure-Fatigue-What-You-Should-Know.pdf. Accessed September 24, 2020.
- Wallin MT, Culpepper WJ, Campbell JD, et al. The prevalence of MS in the United States: a population-based estimate using health claims data. Neurology. 2019;92(10):e1029–e1040. doi: 10.1212/WNL.0000000000007035
- Zwibel HL, Smrtka J. Improving quality of life in multiple sclerosis: an unmet need. Am J Manag Care. 2011;17(Suppl 5):S139–S145.
- Comi G, Radaelli M, Soelberg Sorensen P. Evolving concepts in the treatment of relapsing multiple sclerosis. Lancet. 2017;389(10076):1347–1356. doi: 10.1016/S0140-6736(16)32388-1
- Martin S, Olayinka-Amao O, Henke C, Kamudoni P, Gnanasakthy A. Conceptual model and instrument review in multiple sclerosis [abstract PND53]. Value Health. 2017;20(9):PA726–PA727. doi: 10.1016/j.jval.2017.08.1967
- Col NF, Solomon AJ, Springmann V, et al. Whose preferences matter? A patient-centered approach for eliciting treatment goals. Med Decis Making. 2018;38(1):44–55. doi: 10.1177/0272989X17724434
- Eskyte I, Manzano A, Pepper G, et al. Understanding treatment decisions from the perspective of people with relapsing remitting multiple sclerosis: a critical interpretive synthesis. Mult Scler Relat Disord. 2019;27:370–377. doi: 10.1016/j.msard.2018.11.016
- Webb EJD, Meads D, Eskyte I, et al. A systematic review of discrete-choice experiments and conjoint analysis studies in people with multiple sclerosis. Patient. 2018;11(4):391–402. doi: 10.1007/s40271-017-0296-y
- Rising KL, LaNoue M, Gentsch AT, et al. The power of the group: comparison of interviews and group concept mapping for identifying patient-important outcomes of care. BMC Med Res Methodol. 2019;19(1):7. doi: 10.1186/s12874-018-0656-x
- Rosas SR, Camphausen LC. The use of concept mapping for scale development and validation in evaluation. Eval Program Plann. 2007;30(2):125–135. doi: 10.1016/j.evalprogplan.2007.01.003
- Concept Systems Incorporated. Concept Systems global MAX™; 2019. Available from: www.conceptsystems.com/home. Accessed April 12, 2021.
- Kane M, Trochim WMK. Concept Mapping for Planning and Evaluation. Vol 50. In: Bickman L, Rog DJ, editors. Thousand Oaks, CA: Sage Publications, Inc.; 2007. doi:10.4135/9781412983730
- Kane M, Rosas S. Conversations About Group Concept Mapping: Applications, Examples, and Enhancements. Los Angeles, CA: Sage Publications, Inc.; 2018.
- Davison M. Multidimensional Scaling. New York: Wiley; 1983.